Drugs that contain Trabectedin

1. List of Yondelis drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8895557 JANSSEN PRODS Pharmaceutical formulations of ecteinascidin compounds
Jan, 2028

(4 years from now)

US8895557

(Pediatric)

JANSSEN PRODS Pharmaceutical formulations of ecteinascidin compounds
Jul, 2028

(5 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Oct 23, 2022
Pediatric Exclusivity (PED) Apr 23, 2023

Market Authorisation Date: 23 October, 2015

Treatment: NA

Dosage: POWDER;INTRAVENOUS

How can I launch a generic of YONDELIS before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic